Landmesser U, Laufs U, Schatz U, Winzer EB, et al. Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran's early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hyp Am Heart J 2025;289:117-126.
PMID: 40436308